TNF-α is the major meditator of inflammation and specific blockade of TNF-α with drugs such as infliximab and etanercept were demonstrated to have great efficacy in the treatment of IBD patients (Yao et al., 2019). The gene discussed is TNF; the disease is inflammatory bowel disease.